These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 24388722)

  • 1. Generalized bullous fixed drug eruption is distinct from Stevens-Johnson syndrome/toxic epidermal necrolysis by immunohistopathological features.
    Cho YT; Lin JW; Chen YC; Chang CY; Hsiao CH; Chung WH; Chu CY
    J Am Acad Dermatol; 2014 Mar; 70(3):539-48. PubMed ID: 24388722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized bullous fixed drug eruption imitating toxic epidermal necrolysis: a case report and literature review.
    Mitre V; Applebaum DS; Albahrani Y; Hsu S
    Dermatol Online J; 2017 Jul; 23(7):. PubMed ID: 29469697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosis of generalized bullous fixed drug eruption: comparison with Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Lipowicz S; Sekula P; Ingen-Housz-Oro S; Liss Y; Sassolas B; Dunant A; Roujeau JC; Mockenhaupt M
    Br J Dermatol; 2013 Apr; 168(4):726-32. PubMed ID: 23413807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
    Iwai S; Sueki H; Watanabe H; Sasaki Y; Suzuki T; Iijima M
    J Dermatol; 2012 Sep; 39(9):781-6. PubMed ID: 22458564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical resemblance of widespread bullous fixed drug eruption to Stevens-Johnson syndrome or toxic epidermal necrolysis: report of two cases.
    Lin TK; Hsu MM; Lee JY
    J Formos Med Assoc; 2002 Aug; 101(8):572-6. PubMed ID: 12440088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption.
    Anderson HJ; Lee JB
    Medicina (Kaunas); 2021 Sep; 57(9):. PubMed ID: 34577848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonpigmenting fixed drug eruption as a possible abortive variant of toxic epidermal necrolysis: immunohistochemical and serum cytokine analyses.
    Mizukawa Y; Shiohara T
    Clin Exp Dermatol; 2010 Jul; 35(5):493-7. PubMed ID: 19874369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detecting Lesional Granulysin Levels for Rapid Diagnosis of Cytotoxic T lymphocyte-Mediated Bullous Skin Disorders.
    Chen CB; Kuo KL; Wang CW; Lu CW; Chung-Yee Hui R; Lu KL; Chang WC; Chen WT; Yun F; Teng YC; Lee HE; Lin JY; Ho HC; Chi MH; Yu-Wei Lin Y; Chang CJ; Lin Y; Ku CL; Hung SI; Chang YC; Chung WH;
    J Allergy Clin Immunol Pract; 2021 Mar; 9(3):1327-1337.e3. PubMed ID: 33039642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Chung WH; Hung SI; Yang JY; Su SC; Huang SP; Wei CY; Chin SW; Chiou CC; Chu SC; Ho HC; Yang CH; Lu CF; Wu JY; Liao YD; Chen YT
    Nat Med; 2008 Dec; 14(12):1343-50. PubMed ID: 19029983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid immunochromatographic test for serum granulysin is useful for the prediction of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Fujita Y; Yoshioka N; Abe R; Murata J; Hoshina D; Mae H; Shimizu H
    J Am Acad Dermatol; 2011 Jul; 65(1):65-8. PubMed ID: 21507517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bullous fixed drug eruption masquerading as recurrent Stevens Johnson syndrome.
    Dharamsi FM; Michener MD; Dharamsi JW
    J Emerg Med; 2015 May; 48(5):551-4. PubMed ID: 25433836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.
    Ziemer M; Kardaun SH; Liss Y; Mockenhaupt M
    Br J Dermatol; 2012 Mar; 166(3):575-600. PubMed ID: 22014091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test.
    Porebski G; Pecaric-Petkovic T; Groux-Keller M; Bosak M; Kawabata TT; Pichler WJ
    Clin Exp Allergy; 2013 Sep; 43(9):1027-37. PubMed ID: 23957338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Unintended rechallenge : Generalized bullous fixed drug eruption in two elderly women].
    Paulmann M; Mockenhaupt M
    Hautarzt; 2017 Jan; 68(1):59-63. PubMed ID: 27448063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histological features of fixed drug eruption: a single-centre series of 73 cases with comparison between bullous and non-bullous forms.
    Perron E; Viarnaud A; Marciano L; Karkouche R; Wechsler J; De Prost N; Chosidow O; Wolkenstein P; Ingen-Housz-Oro S; Ortonne N
    Eur J Dermatol; 2021 Jun; 31(3):372-380. PubMed ID: 34309522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand.
    Abe R; Shimizu T; Shibaki A; Nakamura H; Watanabe H; Shimizu H
    Am J Pathol; 2003 May; 162(5):1515-20. PubMed ID: 12707034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV infection predisposes skin to toxic epidermal necrolysis via depletion of skin-directed CD4⁺ T cells.
    Yang C; Mosam A; Mankahla A; Dlova N; Saavedra A
    J Am Acad Dermatol; 2014 Jun; 70(6):1096-102. PubMed ID: 24629995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y; Shibuya M; Izaki S
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fixed Drug Eruptions: An Update, Emphasizing the Potentially Lethal Generalized Bullous Fixed Drug Eruption.
    Patel S; John AM; Handler MZ; Schwartz RA
    Am J Clin Dermatol; 2020 Jun; 21(3):393-399. PubMed ID: 32002848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.